← All organizations

Etablissement Français du Sang

Academic/HospitalWebsite ↗

Also known as: Etablissement francais du sang | Etablissement Français du Sang | ETABLISSEMENT FRANCAIS DU SANG (EFS)

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Last known activity

Mar 12, 2025

Timeline

2000s

Jan 1, 2000
Etablissement Français du Sang— Founded

Drugs by trial phase (14 distinct, 16 trials)

Phase 4 (3 own, 0 via acquisition)

Phase 3 (2 own, 0 via acquisition)

Phase 2 (6 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

geniusvac-mel4

Other trials (2 own, 0 via acquisition)

Indications

Studied for

Recent trials (16)

NCT06809010Lead sponsorN/AMar 12, 2025
NCT06592703CollaboratorPhase 1Oct 31, 2024
NCT04345991CollaboratorPhase 2Apr 14, 2020
NCT03968198CollaboratorPhase 2Jul 31, 2019
NCT03570450CollaboratorPhase 1Jun 2, 2018
NCT02849886CollaboratorPhase 1/Phase 2Oct 1, 2016
NCT02838069CollaboratorPhase 2Sep 1, 2016
NCT02849613CollaboratorPhase 2/Phase 3Mar 31, 2016
NCT02342171CollaboratorPhase 2/Phase 3Feb 28, 2015
NCT01863108CollaboratorPhase 1Jun 1, 2013
NCT01789762Lead sponsorPhase 4May 1, 2013
NCT00929266Lead sponsorN/AMay 1, 2010
NCT00930566Overall official - principal investigatorPhase 1/Phase 2Apr 1, 2009
NCT01619189CollaboratorPhase 2Jun 1, 2007
NCT00235183Lead sponsorPhase 4Jun 30, 2005

Details

Founded: Saint-Denis, FR Jan 1, 2000
Last known activity: Mar 12, 2025